— Know what they know.
Not Investment Advice

HBRM OTC

Herborium Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +9900.0% 1Y: +0.0% 3Y: -33.3% 5Y: -94.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $1.1M mcap · 8.53B float · 0.0060% daily turnover · Short 20% of daily vol

Cash Flow Trends

Operating Cash Flow
$370K +377.6% ▲
Capital Expenditures
$2K -15.6% ▼
Free Cash Flow
$368K +372.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$3K -159.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$76K$47K-$329K-$267K$30K
Depreciation & Amort.$6K$6K$6K$4K$0
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$1K-$96K$423K$129K$334K
Other Non-Cash Items$0$0-$6K$0$6K
Operating Cash Flow-$71K-$43K$94K-$133K$370K
— Investing Activities —
Capital Expenditures$0$0$0-$2K-$2K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0$0$0-$2K-$2K
— Financing Activities —
Net Debt Issuance$0-$14K$0$0-$227
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$48K$112K-$100K$145K-$371K
Financing Cash Flow$48K$98K-$100K$145K-$371K
Net Change in Cash-$3K$8K-$6K$6K-$3K
Cash End of Period$6K$14K$8K$14K$10K
Free Cash Flow-$71K-$43K$94K-$135K$368K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms